Your browser doesn't support javascript.
loading
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
Hyman, David M; Zhou, Qin; Iasonos, Alexia; Grisham, Rachel N; Arnold, Angela G; Phillips, Mary F; Bhatia, Jasmine; Levine, Douglas A; Aghajanian, Carol; Offit, Kenneth; Barakat, Richard R; Spriggs, David R; Kauff, Noah D.
Afiliação
  • Hyman DM; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Cancer ; 118(15): 3703-9, 2012 Aug 01.
Article em En | MEDLINE | ID: mdl-22139894
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Genes BRCA1 / Genes BRCA2 / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Genes BRCA1 / Genes BRCA2 / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article